CIK 0001093557 · Large accelerated filer
DEXCOM INC
Sign in to watch- Ticker
- DXCM
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330857544
- Phone
- 8582000200
- Business address
- 6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Auditor change
- 4 Planned sale Director sold 352 shares at $70.33 ($24,756)
- 144 Insider Sale of Securities
- 4 Open-market sale EVP, Chief Operating Officer sold 14,076 shares at $70.38 ($990,670)
- 4 Open-market sale EVP, Chief Legal Officer sold 13,000 shares at $70.38 ($914,941)
- 4 Open-market sale EVP, Chief Financal Officer sold 12,001 shares at $70.38 ($844,632)
- 4 Open-market sale EVP, Chief HR Officer sold 11,176 shares at $70.38 ($786,568)
- 4 Open-market sale Chairman, CEO & President sold 32,498 shares at $70.38 ($2,287,212)
- 4 Grant or award Chairman, CEO & President acquired 85,490 shares (grant or award)
- 4 Grant or award EVP, Chief Operating Officer acquired 58,704 shares (grant or award)
- 4 Grant or award EVP, Chief HR Officer acquired 52,720 shares (grant or award)
- 4 Grant or award EVP, Chief Legal Officer acquired 52,720 shares (grant or award)
- 4 Planned sale EVP, Chief Financal Officer sold 7,000 shares at an average $73.83 ($516,830)
Page 10 of 133 · 2,656 filings